Prenetics Global Limited's wellness brand IM8 has closed a $1 billion growth financing deal with General Catalyst’s Customer Value Fund, which will cover up to 70% of IM8’s marketing spend. This non-dilutive financing allows IM8 to accelerate its expansion across 43 countries while preserving Prenetics’ balance sheet. IM8, co-founded by David Beckham, is the fastest-growing premium supplement brand, with revenue guidance raised to $210–220 million for 2026 and expectations to reach $300 million by year-end. The funding supports IM8’s AI-driven marketing engine and ongoing product innovation, positioning the brand for over $400 million in revenue in 2027 and long-term global leadership in consumer health.
Tencent Music Entertainment is moving from traditional streaming to a fan-centered, IP-driven business model using concerts, merchandise, and premium content. The company integrates AI to speed music creation, boost engagement, and cut costs, aiming ...
Sandisk has surged following recent financial updates and is highlighted as a top value stock with strong long-term growth fundamentals. Despite markets reaching all-time highs and volatility in sectors like tech, Sandisk and two other value stocks o...
SpaceX shares dropped about 28.6% from $196 on June 15 to $140 by August 15, two months after its historic IPO that valued the company at $1.77 trillion. Despite this decline, SpaceX reported strong quarterly growth with revenue up 92% to $7.8 billio...
XRP whale inflows to Binance have dropped sharply to $61 million, the lowest since 2021 and down nearly 87% from January 2025 levels, indicating reduced large-holder deposits. Despite this, Binance's XRP netflows remain positive at $18.8 million, sho...
Coinfello has upgraded its AI platform, Fello 2, enabling users to automate complex DeFi strategies using simple plain-language commands. This innovation removes the need for manual multi-step interactions across multiple dApps, reducing user fatigue...
